Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)

A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated:  4/8/2013
Jeffrey Schultz, M.D.
mi
from
Bronx, NY
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
Jeffrey Schultz, M.D.
mi
from
Bronx, NY
Click here to add this to my saved trials
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated:  4/8/2013
Ophthalmic Consultants of Long Island
mi
from
Lynbrook, NY
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
Ophthalmic Consultants of Long Island
mi
from
Lynbrook, NY
Click here to add this to my saved trials
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated:  4/8/2013
Rochester Ophthalmological Group
mi
from
Rochester, NY
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
Rochester Ophthalmological Group
mi
from
Rochester, NY
Click here to add this to my saved trials
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated:  4/8/2013
Charlotte Eye, Ear, Nose & Throat Associates
mi
from
Charlotte, NC
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
Charlotte Eye, Ear, Nose & Throat Associates
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated:  4/8/2013
The Eye Institute
mi
from
Tulsa, OK
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
The Eye Institute
mi
from
Tulsa, OK
Click here to add this to my saved trials
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated:  4/8/2013
Texan Eye
mi
from
Austin, TX
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
Texan Eye
mi
from
Austin, TX
Click here to add this to my saved trials
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated:  4/8/2013
Medical Center Ophth. Associates
mi
from
San Antonio, TX
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
Medical Center Ophth. Associates
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated:  4/8/2013
Stacy R. Smith, M.D.
mi
from
Salt Lake City, UT
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
Stacy R. Smith, M.D.
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated:  4/8/2013
Virginia Eye Consultants
mi
from
Norfolk, VA
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
A Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components
Status: Enrolling
Updated: 4/8/2013
Virginia Eye Consultants
mi
from
Norfolk, VA
Click here to add this to my saved trials
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Safety and Pharmacokinetics of Lisinopril in Pediatric Kidney Transplant Recipients
Status: Enrolling
Updated:  4/22/2013
University of Alabama at Birmingham
mi
from
Birmingham, AL
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Safety and Pharmacokinetics of Lisinopril in Pediatric Kidney Transplant Recipients
Status: Enrolling
Updated: 4/22/2013
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Safety and Pharmacokinetics of Lisinopril in Pediatric Kidney Transplant Recipients
Status: Enrolling
Updated:  4/22/2013
Arkansas Children's Hospital
mi
from
Little Rock, AR
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Safety and Pharmacokinetics of Lisinopril in Pediatric Kidney Transplant Recipients
Status: Enrolling
Updated: 4/22/2013
Arkansas Children's Hospital
mi
from
Little Rock, AR
Click here to add this to my saved trials
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Safety and Pharmacokinetics of Lisinopril in Pediatric Kidney Transplant Recipients
Status: Enrolling
Updated:  4/22/2013
Emory University/Childrens Healthcare of Atlanta
mi
from
Atlanta, GA
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Safety and Pharmacokinetics of Lisinopril in Pediatric Kidney Transplant Recipients
Status: Enrolling
Updated: 4/22/2013
Emory University/Childrens Healthcare of Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Safety and Pharmacokinetics of Lisinopril in Pediatric Kidney Transplant Recipients
Status: Enrolling
Updated:  4/22/2013
University of Michigan
mi
from
Ann Arbor, MI
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Safety and Pharmacokinetics of Lisinopril in Pediatric Kidney Transplant Recipients
Status: Enrolling
Updated: 4/22/2013
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Safety and Pharmacokinetics of Lisinopril in Pediatric Kidney Transplant Recipients
Status: Enrolling
Updated:  4/22/2013
Children's Mercy Hospital
mi
from
Kansas City, MO
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Safety and Pharmacokinetics of Lisinopril in Pediatric Kidney Transplant Recipients
Status: Enrolling
Updated: 4/22/2013
Children's Mercy Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Safety and Pharmacokinetics of Lisinopril in Pediatric Kidney Transplant Recipients
Status: Enrolling
Updated:  4/22/2013
Albert Einstein University Hospital
mi
from
Bronx, NY
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Safety and Pharmacokinetics of Lisinopril in Pediatric Kidney Transplant Recipients
Status: Enrolling
Updated: 4/22/2013
Albert Einstein University Hospital
mi
from
Bronx, NY
Click here to add this to my saved trials
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Safety and Pharmacokinetics of Lisinopril in Pediatric Kidney Transplant Recipients
Status: Enrolling
Updated:  4/22/2013
New York University Langone Medical Center
mi
from
New York, NY
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Safety and Pharmacokinetics of Lisinopril in Pediatric Kidney Transplant Recipients
Status: Enrolling
Updated: 4/22/2013
New York University Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Safety and Pharmacokinetics of Lisinopril in Pediatric Kidney Transplant Recipients
Status: Enrolling
Updated:  4/22/2013
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant
Safety and Pharmacokinetics of Lisinopril in Pediatric Kidney Transplant Recipients
Status: Enrolling
Updated: 4/22/2013
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Efficacy of Changing to Travatan From Prior Therapy
Multi-Center Study Comparing Efficacy and Tolerability of TRAVATAN® BAK-free (0.004% Travoprost) in Patients Previously on Latanoprost Ophthalmic Solution 0.005% Monotherapy
Status: Enrolling
Updated:  4/22/2013
Alcon Call Center
mi
from
Fort Worth, TX
Efficacy of Changing to Travatan From Prior Therapy
Multi-Center Study Comparing Efficacy and Tolerability of TRAVATAN® BAK-free (0.004% Travoprost) in Patients Previously on Latanoprost Ophthalmic Solution 0.005% Monotherapy
Status: Enrolling
Updated: 4/22/2013
Alcon Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  5/10/2013
Saint Joseph's Hospital
mi
from
Phoenix, AZ
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 5/10/2013
Saint Joseph's Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  5/10/2013
UCSD Medical Center
mi
from
La Jolla, CA
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 5/10/2013
UCSD Medical Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  5/10/2013
UCLA Medical Center
mi
from
Torrance, CA
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 5/10/2013
UCLA Medical Center
mi
from
Torrance, CA
Click here to add this to my saved trials
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  5/10/2013
University of Colorado Denver
mi
from
Aurora, CO
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 5/10/2013
University of Colorado Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  5/10/2013
Kentuckiana Pulmonary Associates
mi
from
Louisville, KY
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 5/10/2013
Kentuckiana Pulmonary Associates
mi
from
Louisville, KY
Click here to add this to my saved trials
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  5/10/2013
University of Maryland Medical Center
mi
from
Baltimore, MD
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 5/10/2013
University of Maryland Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  5/10/2013
Tufts Medical Center
mi
from
Boston, MA
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 5/10/2013
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  5/10/2013
Boston University School of Medicine
mi
from
Boston, MA
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 5/10/2013
Boston University School of Medicine
mi
from
Boston, MA
Click here to add this to my saved trials
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  5/10/2013
Brigham and Women's Hosp
mi
from
Boston, MA
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 5/10/2013
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  5/10/2013
Washington University School of Medicine
mi
from
Saint Louis, MO
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 5/10/2013
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  5/10/2013
Duke Univ Med Ctr
mi
from
Durham, NC
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 5/10/2013
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  5/10/2013
University of Cincinnati
mi
from
Cincinnati, OH
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 5/10/2013
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  5/10/2013
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 5/10/2013
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  5/10/2013
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 5/10/2013
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  5/10/2013
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 5/10/2013
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  5/10/2013
Baylor College of Medicine
mi
from
Houston, TX
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 5/10/2013
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  5/10/2013
Inova Fairfax Hospital
mi
from
Falls Church, VA
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 5/10/2013
Inova Fairfax Hospital
mi
from
Falls Church, VA
Click here to add this to my saved trials
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated:  5/10/2013
Aurora St. Luke's Medical Center
mi
from
Milwaukee, WI
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Status: Enrolling
Updated: 5/10/2013
Aurora St. Luke's Medical Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  5/10/2013
Saint Joseph's Hospital
mi
from
Phoenix, AZ
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 5/10/2013
Saint Joseph's Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  5/10/2013
UCSD Medical Center
mi
from
La Jolla, CA
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 5/10/2013
UCSD Medical Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  5/10/2013
UCLA Medical Center
mi
from
Torrance, CA
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 5/10/2013
UCLA Medical Center
mi
from
Torrance, CA
Click here to add this to my saved trials
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  5/10/2013
University of Colorado Denver
mi
from
Aurora, CO
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 5/10/2013
University of Colorado Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  5/10/2013
Kentuckiana Pulmonary Associates
mi
from
Louisville, KY
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 5/10/2013
Kentuckiana Pulmonary Associates
mi
from
Louisville, KY
Click here to add this to my saved trials
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  5/10/2013
University of Maryland Medical Center
mi
from
Baltimore, MD
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 5/10/2013
University of Maryland Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  5/10/2013
Tufts Medical Center
mi
from
Boston, MA
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 5/10/2013
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  5/10/2013
Boston University School of Medicine
mi
from
Boston, MA
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 5/10/2013
Boston University School of Medicine
mi
from
Boston, MA
Click here to add this to my saved trials
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  5/10/2013
Brigham and Women's Hosp
mi
from
Boston, MA
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 5/10/2013
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  5/10/2013
Washington University School of Medicine
mi
from
Saint Louis, MO
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 5/10/2013
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  5/10/2013
Duke Univ Med Ctr
mi
from
Durham, NC
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 5/10/2013
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  5/10/2013
University of Cincinnati
mi
from
Cincinnati, OH
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 5/10/2013
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  5/10/2013
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 5/10/2013
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  5/10/2013
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 5/10/2013
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials